IL17A and psoriasis: Results also showed that hGMSCs increased the percentage of spleen IL-17+CD3+ regulatory T (Treg) cells and decreased the percentage of spleen IL-17+CD3+T-cells (a type of Th-17 cells), suggesting that hGMSCs are exhibit therapeutic effects in psoriasis.